Changes in the Evaluation and Management of Adrenocortical Carcinoma

Excerpt

For decades, little progress was made in improving outcomes for patients with adrenocortical carcinoma (ACC). During the past 15 years, an increased understanding of the biology underlying this disease has led to better care and slow improvement of outcomes. The collaborative work of higher-volume centers and the development of several ACC networks around the world have been instrumental to this progress because the limited number of patients with ACC had previously made the ability to conduct randomized clinical trials nearly impossible. The Society of Surgical Oncology Endocrine Disease Site Working Group has presented a broad review of key elements to be considered in the care of patients with ACC. As is noted in part 1 the update is neither a consensus guideline nor a position statement, but rather an effort to disseminate selected data and opinions regarding care for a subject few regularly spend considerable time reviewing and even fewer treat in their clinical practice. …